Liver Progenitor Cell Isolation via Hepatic Marker Selection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for isolating liver stem cells primarily yield hepatic oval stem cells, which are morphologically and molecularly distinct from a novel progenitor cell population that expresses hepatic cell markers and lacks hematopoietic markers, limiting the availability of pluripotent progenitor cells for regenerative therapies.

Innovation Solution

A method involving culturing adult liver-derived mature hepatocytes until their death, followed by selection and expansion of surviving epithelioid cells in a serum-containing medium with hEGF and bFGF, allowing for the isolation of non-oval human liver progenitor cells that express hepatic markers and exhibit self-renewal and multilineage differentiation potential.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional methods are used to isolate liver stem cells, then hepatic oval stem cells are obtained, but these cells lack pluripotent differentiation potential and express hematopoietic markers rather than hepatic markers

Engineering Contradiction:
Improvedifferentiation potentialVSAvoidcell marker expression profile
Core Design Contradiction:
ReliabilityVSMeasurement precision

Solution Approach 1:

The invention extracts and isolates a specific subpopulation of liver stem cells that express hepatic markers (albumin, α-fetoprotein) while excluding cells that express hematopoietic markers. This is achieved through selective culturing conditions and marker-based identification to obtain cells with genuine hepatic differentiation potential.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention identifies and cultivates liver stem cells with specific local qualities - expressing hepatic cell markers (albumin, α-fetoprotein) rather than hematopoietic markers. This selective cultivation based on marker expression profiles ensures the isolated cells possess the desired differentiation potential toward hepatic lineages.

Inventive Principle:
Principle #3Local quality

2Productivity

If hepatic oval stem cells are isolated using conventional methods, then cells with characteristic oval morphology are obtained, but these cells do not exhibit self-renewal capability and multilineage differentiation potential

Engineering Contradiction:
Improveself-renewal capabilityVSAvoidcell morphology
Core Design Contradiction:
ProductivityVSShape

Solution Approach 1:

The invention changes the cultivation parameters and selection criteria to isolate liver stem cells based on marker expression (albumin, α-fetoprotein positivity) rather than morphological characteristics. This parameter change from morphology-based to marker-based identification enables the isolation of cells with self-renewal capability and multilineage differentiation potential, regardless of their shape.

Inventive Principle:
Principle #35Parameter changes

3Measurement precision

If conventional isolation methods are applied, then liver stem cells are obtained, but the method does not provide a reliable way to distinguish true hepatic progenitor cells from cells of hematopoietic origin

Engineering Contradiction:
Improvecell origin identificationVSAvoidisolation method complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The invention uses marker expression profiles (albumin, α-fetoprotein, CK18 positivity) as biochemical 'color codes' to identify and distinguish true hepatic progenitor cells from hematopoietic-derived cells. This marker-based identification system provides a reliable method to differentiate cell origins without requiring complex additional assays.

Inventive Principle:
Principle #32Color changes

Data Source

PatentUS9334479B2Liver progenitor cells
Publication Date: 2016.05.10 FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
  • US9334479B2 patent drawing
  • US9334479B2 patent drawing

AI summary

The invention relates to human liver pluripotent progenitor cell lines which express hepatic cell markers such as albumin and α-fetoprotein and do not express some of the markers which are typical of oval stem cells. Also disclosed is a method of isolating the cell lines of the invention, methods for differentiating said cells into a plurality of different cell lineages, methods for conditional immortalization and metabolic selection of said cells, as well as the use of the cell lines of the invention for preparing a medicament with osteogenic differentiation activity or liver injury regeneration activity.